The length of treatment depends on your individual health profile and weight loss goals
Medication choice should be determined by symptom coverage, side effects, and medical history
Just based on two high level metrics when it was removed from the shortage list (based on pharmacy supply calls and patients pick up rates here at Ro): Pharmacy Supply Calls: 38% of pharmacies have stock 15% do not have stock but expect to have it in the future 48% say its on back order and materially less supply than other Wegovy doses Patient pick up rates: 30-35% are able to find supply in 14 days 65-70% are able to find supply in 30 days If providers are using the FDAs list to determine what path to recommend for their patients, we need to ensure the FDA has as much information as possible to make that determination
[37] indicate that APO improves AHR, lowers the concentration of IL-4 and IL-13, and inhibits the activity of eosinophil peroxidase
Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W (1995) Reduced awareness of hypoglycemia in adults with IDDM